• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Inhibitory effects of glucosylceramide on tumorigenesis induced by a carcinogen in mice

Research Project

Project/Area Number 16K11233
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Otorhinolaryngology
Research InstitutionTottori University

Principal Investigator

FUJIWARA Kazunori  鳥取大学, 医学部, 准教授 (90403419)

Co-Investigator(Kenkyū-buntansha) 矢間 敬章  鳥取大学, 医学部, 助教 (30444631)
Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2018: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords頭頸部癌 / セラミド / 発癌予防 / 発がん予防 / スフィンゴ脂質 / 癌
Outline of Final Research Achievements

In head and neck squamous cell carcinoma, preventing recurrence and second primary cancer is required to improve prognosis. The purpose of the present study was to determine whether dietary glucosylceramide(GluCer) had anti-carcinogenic and anti-tumorigenic effects in a mouse model of HNSCC.
All CB6F1-Tg rasH2@Jcl mice were given 4-nitroquinoline 1-oxide for 24 weeks. GluCer group mice were given a mixture of the normal diet plus GluCer for 24 weeks. Epithelial regions were classified as normal tissue, carcinoma in situ (CIS), or SCC, and the number of each type of region was counted. Compared with the GluCer group mice, control group mice more frequently developed individual and multiple tumors of each type, including CIS and SCC, in the mouth, pharynx, or esophagus. Tumor development was effectively inhibited by dietary glucosylceramide derived from rice bran, indicating that this and related compounds show promise as prophylactic agents for human HNSCC.

Academic Significance and Societal Importance of the Research Achievements

本研究では、グルコシルセラミドが発癌予防効果を示した。また、使用したグルコシルセラミドは植物由来の抽出物であるため、服用の安全性も高いと考えられる。そのため、本物質が癌予防としての効果を有する物質になる可能性が期待される。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (5 results)

All 2019 2018 2016

All Presentation (5 results)

  • [Presentation] グルコシルセラミドによる頭頸部癌の発生抑制効果2019

    • Author(s)
      藤原和典
    • Organizer
      日本耳鼻咽喉科学会
    • Related Report
      2018 Annual Research Report
  • [Presentation] グルコシルセラミドによる頭頸部癌の発生抑制効果2018

    • Author(s)
      藤原和典
    • Organizer
      日本気管食道科学会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 経口グルコシルセラミド投与による頭頸部癌抑制効果に関する臨床試験2018

    • Author(s)
      藤原和典
    • Organizer
      スフィンゴテラピー研究会
    • Related Report
      2018 Annual Research Report
  • [Presentation] セラミドによる甲状腺未分化癌細胞浸潤転移能抑制効果の検討2016

    • Author(s)
      藤原和典、矢間敬章、竹内裕美
    • Organizer
      日本気管食道科学会
    • Place of Presentation
      京王プラザホテル(東京)
    • Year and Date
      2016-11-18
    • Related Report
      2016 Research-status Report
  • [Presentation] 米糠由来グルコシルセラミドの抗腫瘍効果2016

    • Author(s)
      矢間敬章、藤原和典、竹内裕美
    • Organizer
      日本耳鼻咽喉科学会
    • Place of Presentation
      名古屋国際会議場(愛知県)
    • Year and Date
      2016-05-21
    • Related Report
      2016 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi